Mef2d potentiates type-2 immune responses and allergic lung inflammation

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Innate lymphoid cells (ILCs) and T lymphocytes are crucial for tissue homeostasis and immune responses.
• GATA3 transcription factor is essential for ILC and T cell development and type-2 immunity.
• The regulation of GATA3 up-regulation in type-2 lymphocytes is not well understood.

Purpose of the Study:

• To identify novel regulators of GATA3-dependent type-2 lymphocyte differentiation.
• To investigate the role of myocyte-specific enhancer factor 2d (Mef2d) in type-2 immunity.

Main Methods:

• CRISPR screens in ILCs.
• Genetic deletion of Mef2d in ILC2s and T cells.
• Allergen lung challenge model.
• Analysis of gene expression and signaling pathways (e.g., IL-33 signaling, NFAT1 translocation).

Main Results:

• CRISPR screens identified Mef2d as a regulator of GATA3 expression in ILCs.
• Mef2d deletion in ILC2s and/or T cells conferred protection against allergen-induced lung inflammation.
• Mef2d was found to repress Regnase-1, leading to increased IL-33 receptor and enhanced IL-33 signaling.
• Mef2d acts downstream of calcium signaling to promote NFAT1 nuclear translocation and type-2 cytokine production.

Conclusions:

• Mef2d is a critical regulator of GATA3-dependent type-2 lymphocyte differentiation and function.
• Mef2d plays a significant role in allergic lung inflammation.
• Targeting Mef2d could be a therapeutic strategy for type-2 immune disorders.